3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Muscular Atrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blobner, M; Jeevendra Martyn, JA; Kem, WR; Khan, MAS; Lewald, H; Nagashima, M; Sasakawa, T; Schaller, SJ; Schlegel, J; Schneider, G; Schönfelder, M; Schulz, F | 1 |
| Goto, T; Kaneki, M; Kashiwagi, S; Kem, WR; Khan, MA; Martyn, JA; Tompkins, RG; Yasuhara, S | 1 |
2 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Muscular Atrophy
| Article | Year |
|---|---|
GTS-21 attenuates loss of body mass, muscle mass, and function in rats having systemic inflammation with and without disuse atrophy.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Body Weight; Corynebacterium Infections; Immobilization; Male; Methemoglobin; Muscle, Skeletal; Muscular Atrophy; Nicotinic Agonists; Pyridines; Rats; Rats, Sprague-Dawley; Systemic Inflammatory Response Syndrome | 2018 |
Prevention of Burn-Induced Inflammatory Responses and Muscle Wasting by GTS-21, a Specific Agonist for α7 Nicotinic Acetylcholine Receptors.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Burns; Immunoblotting; Inflammation; Male; Mice; Mice, Inbred C57BL; Muscular Atrophy; Pyridines | 2017 |